Reduced surgical invasiveness – enhance your patient’s benefits

Every day nearly 500 women are diagnosed with a gynaecological malignancy in Europe.1 Thanks to national screening programmes and regular check-ups, these cancers are often detected at an early stage.2-4 Even more luckily for these patients, the current clinical trend is moving toward less invasive surgical approaches which, combined with precision diagnostics, are leading to a great improvement in patient prognosis and quality of life.5-7

Sysmex supports innovation in healthcare with a cutting-edge solution.

  • Multiple patients could avoid unnecessary extended lymphadenectomies and related morbidities by implementing the sentinel lymph node biopsy concept.
  • You no longer need radioactive markers to detect sentinel lymph nodes as the Sentimag®/Magtrace® system detects them magnetically.


  1.  Ferlay J et al. (2013): Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 49(6):1374-403.
  2.  Vu M et al. (2018): Cervical cancer worldwide. Curr Probl Cancer. pii: S0147-0272(18)30134-X.
  3. Ogilvie G et al. (2017): Optimizing secondary prevention of cervical cancer: Recent advances and future challenges. Int J Gynaecol Obstet. 138 Suppl 1:15-19.
  4. Braun M et al. (2016): Diagnosis and Management of Endometrial Cancer. Am Fam Physician. 93(6):468-74.
  5. Shisler R et al.(2018): Life after endometrial cancer: A systematic review of patient-reported outcomes. Gynecol Oncol. 148(2):403-413.
  6. Frost JA et al.(2017): Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 10:CD007585.
  7. Zigras T et al. (2017): Early Cervical Cancer: Current Dilemmas of Staging and Surgery. Curr Oncol Rep. 19(8):51.


Oncology Report - New Customer Magazine

Watch the video
A patient report
Enjoy our Media Centre
  • All
  • Documents
  • Podcast
  • Images
  • Videos
Sysmex Urinalysis
See the features